Anergia prevalent in acute coronary syndrome patients

October 21, 2012

(HealthDay)—Anergia, or the lack of energy, is highly prevalent in patients with acute coronary syndromes (ACS), and correlates independently with several factors, including bodily pain and exercise participation, according to a study published in the Nov. 1 issue of The American Journal of Cardiology.

Jonathan A. Shaffer, Ph.D., of Columbia University in New York City, and colleagues conducted a study involving 472 hospitalized patients with ACS enrolled in a to evaluate the prevalence and clinical and demographic characteristics of anergia.

At least one instance of anergia was reported by 79.9 percent of patients, and 32 percent of patients met the established criteria for anergia. The researchers found that anergia correlated independently with being a woman, being white versus black, having bodily pain, participating in exercise, having current depressive disorder, and having elevated values on the Charlson Comorbidity Index, in a multivariable model.

"In conclusion, anergia is a highly prevalent syndrome in patients with ACS," the authors write. "It is distinct from depression and is associated with modifiable clinical factors such as participation in exercise and bodily pain that may be appropriate targets for intervention."

Explore further: Gender, high DAS28-P index predictive of pain in early RA

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Gender, high DAS28-P index predictive of pain in early RA

May 18, 2012

(HealthDay) -- For patients with rheumatoid arthritis (RA), female gender and having a high proportion of disease activity score (DAS28) attributable to patient-reported components (joint tenderness and visual analog score) ...

Recommended for you

No new heart muscle cells in mice after the newborn period

November 5, 2015

A new study from Sweden's Karolinska Institutet shows that new heart muscle cells in mice are mainly formed directly after birth. After the neonatal period the number of heart muscle cells does not change, and A new study ...

Nanotechnology could spur new heart treatment

October 29, 2015

A new nanoparticle developed by University of Michigan researchers could be the key to a targeted therapy for cardiac arrhythmia, a condition that causes the heart to beat erratically and can lead to heart attack and stroke.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.